Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve (a) The Audited Financial ....
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indo Us Bio-Tech Ltd has informed BSE that a Board meeting is scheduled for May 29, 2026. The agenda includes consideration and approval of audited financial results for Q4 and the full year ended March 31, 2026, along with the audited Balance Sheet and Statement of Profit and Loss. The company has also confirmed that the trading window remains closed from April 1, 2026 till May 30, 2026, which is standard practice ahead of price-sensitive announcements. This is a routine regulatory intimation and does not contain any forward-looking statements or material disclosures about company performance.
This is a standard pre-result announcement notice and does not itself contain material information that would directly impact the stock price. The actual financial results will be disclosed after the board meeting, which could trigger volatility depending on whether performance meets, exceeds, or misses market expectations.